Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here is what you won't acknowledge..the P2b is very differnt. patient population is mod to severe(easier and not included in p2a) 300mg and 400mg (again not included in p2a) and they are using a different scoring system(again different than p2a). Also the fda has seen all the data and agreed to let us run the trial. The company has done a great job with trials so far and the result s will be know soon.
Lol! The more prospects you develop the better. That's a big part of Leo's job. If you don't like the job he is doing sell and move on!
Now a corporate ombudsmen! Lol! We have multiple indications for B alone and it's important to create more contacts.
Yep, without revenue it's incumbent on the CEO to promote the company.
Are you going to the conference?
Yes. He stated some BP have requested info on all our drugs. The implication was they were interested in everything.
I think if anyone had read the PRs they would know the trial design for k was inconjuction with potential partners input. How could someone miss that? Lol
"Expressing a reasonable expectation"? Seriously? The poster would of jumped all over a PR that touted any efficacy from such a small study! Lmao!
"Just attempts to limit....somewhat"
Seems like your kind of down playing it a little. B-OM works. Patients will suffer less. Case closed.
Immaturity plain and simple!
If the past is any indication the presentation will be an overview of the company and pipeline. Remember it's a 20 min presentation. The real action will hopefully happen behind close doors.
Interesting but where are their pictures!
Hippa laws give nice cover to create a nice all or nothing argument because the facts can't be revealed but some can project what they think is the only true and real answer. Be careful these arguements seem reasonable until one does their own dd.
The all or nothing argument is probably a better bet. Someone might say something like because you made a mistake you are completely discredited when in fact you neither made a mistake or are discredited. Yes all or nothing can work if you are naive.
I love the straw man technique . Create an argument that can't be refuted. A certain test wasn't released and now an entire drug and trial are completely invalidated. It makes the person seem smart without any effort. Do your own dd. Remember that both P and K were reviewed and allowed to move forward by the FDA and the medical teams involved with the studies.
Companies often will have differnt outcome measurements for same disease. Look at our OM trial is for prevention and our competition is for reduction. 2 different measurements same disease. And oncology is much more complicated.
Did they give info out before trial was done?
Sorry for your loss. I understand your reasoning but I am not buying his act. Way to much drama and very little reasoning. No matter what evidence or trial data is given there is always something that is missing or not up to his standards...seems suspicious to me.
It's to easy for someone to scream and cry about a certain piece of data that wasn't given or isn't good enough from their perspective. It doesn't matter that the medical staff and the fda approved the trial to move forward...just scream and cry! Lmao
But the price went up!
Happy New Year! 2018 will be very exciting!
New investors do your own dd. Read the stickies, go to company website, check out the fda clinical trial site and I think you will have a better understanding of the company and the enormous possibilities.
A brand new poster. Lol They are coming out of the wood work!
How many times do people have to tell you he didn't sell.
So are you suggesting that doctors make all there decisions on one test? Lol The trial has many biomarkers and they will be released when the study is done.
Or someone is just not telling the truth.
Pulling out all the oldies today! Nice try but false.
Come on as give us the info! Quit hiding the secrets!
Dude you have no inquisitive posts! That's his point! Lol
Lmao! They don't pick up prs! It's funny...the company issues a PR and there are more naysers working over time this am! Why?
Classic...no discussion of science just following Mako smear campaign.
You mean that trials take time but the good Dr wants info stat!
This is a update not the end of study report. Remember K was proven safe. If you had read the pr you would of seen more info to follow usually done after completion and at a conference. You are working hard today.
Go back good Dr. And look at the phase 1 data. It was safe!
Dam spell check! Lol yes in this case either works.
New investors be very weary of people who seemingly appear from no where to save you. Do your own dd. Ipix has many catalyst.
Completely ignorant statement. K was a phase 1. What's the primary endpoint? Safety! Did the fda let k move on to phase 2? Yes because it met its primary endpoints for phase 1. Sorry that's how it works. No matter how you try to spin it
If history is our guide BP has given a lot more for a lot less!
Even PR’s that report a trial failure contain positive quotes from management.
When did we have a trial failure?